Ultromics

Ultromics is a company founded at the University of Oxford by leading experts in science and AI, in partnership with the Mayo Clinic in the U.S. and the UK's NHS. It develops AI solutions for cardiovascular imaging diagnostics, with products like EchoGo® for heart failure detection and cardiac amyloidosis screening. The company is backed by investors including Google Ventures, Optum Ventures, and Blue Venture Fund.

Ultromics was founded at the University of Oxford by leading experts in science and AI, in partnership with the Mayo Clinic in the U.S. and the UK's NHS. The company is a global leader in AI-powered cardiovascular imaging diagnostics, spun out from the University of Oxford, UK and built on a decade of world-leading research. It is backed by investors including Google Ventures, Optum Ventures, and Blue Venture Fund.

• EchoGo® Heart Failure

  Advanced AI for identifying patients with HFpEF.

• EchoGo® Amyloidosis

  Advanced AI for screening patients with Cardiac Amyloidosis.

1. EchoGo | AI for detection of HFpEF & Cardiac Amyloidosis | Ultromics
2. Leading Minds in AI and Science | Team Ultromics at Oxford | Ultromics
3. Careers | Ultromics
4. AI-Powered Early Detection of Cardiovascular Disease | Ultromics
5. Ultromics, Ltd. (United Kingdom)